| Literature DB >> 25050056 |
Corey Witenko, Robin Moorman-Li, Carol Motycka, Kevin Duane, Juan Hincapie-Castillo, Paul Leonard, Christopher Valaer.
Abstract
For patients with low back pain, skeletal muscle relaxants are often initiated after failure of first-line analgesics. However, these medications (reviewed in this article) are controversial alternatives that carry risks of adverse effects and increased cost.Entities:
Keywords: Skeletal muscle relaxants; antispasmodic; antispasticity; carisoprodol; controlled substance; low back pain
Year: 2014 PMID: 25050056 PMCID: PMC4103716
Source DB: PubMed Journal: P T ISSN: 1052-1372